Press and Media
View the latest AANEM Achievement Award winners, the American Neuromuscular Foundation (ANF) Abstract Award winners, and the latest AANEM news articles on News Express.
Frequently Asked Questions
Q: When will be content of abstracts be viewable, as opposed to just the titles?
A: The abstract content will be available at the annual meeting during the Poster Hall hours. We do not provide abstract presenter information or slides ahead of time. All available information can be found in the AANEM Abstract Guide online when it becomes available.
Q: How do I reach out to abstract or session presenters for an interview?
A: We do not offer member contact information. To connect with abstract or session presenters, review the AANEM Annual Meeting Program when available. Find the topics of interest and connect with the presenter after their lecture or during their abstract poster session time. Currently there is no interview option for virtual attendees.
Q: When can I share information?
A: The embargo on the abstracts themselves is lifted when they have been published in Muscle & Nerve and online in the AANEM Abstract Guide. However, the additional information beyond what is in the abstract itself is still embargoed.
AANEM requires information that goes beyond that which is contained within the abstract, e.g., the release of data not included in the abstract, discussion of the abstract done as part of a scientific presentation, etc. to be embargoed until the start of the annual meeting. Please see the Abstract Embargo Policy.
Q: Will the Abstract Award Reception feature the best posters?
A: The Abstract Award Reception is a social hour in honor of the abstract award winners where all authors, including award winners, will be available to discuss research.
Q: Original research is ONLY presented as posters, correct?
A: Yes - the research is presented in the Poster Hall via abstract posters.
AANEM Publishes New International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Disease
After several years of extensive work, AANEM’s Practice Issues Review Panel (PIRP)’s Glucocorticoid Related Complications in NM Diseases task force recently published its international consensus statement in Muscle & Nerve. The task force was chaired by Ruple Laughlin, MD, with shared senior authorship among Dr. Laughlin and Drs. Corey Bacher, Pushpa Narayanswami, and Charles Kassardijan. Other members of the task force included: Drs. Mark Bromberg, Frank Buttgereit, Dubravka Dodig, Eoin Flanagan, Chloe Gottlieb, John Marshal, Rozalina McCoy, Sara Mitchell, Protish Tosh, and Partha Sinha. Access the guidance document: International Consensus Guidance for the Management of Glucocorticoid Related Complications in Neuromuscular Disease.
In regards to the project, Dr. Laughlin said, "It is our hope that this work will provide valuable support to all neuromuscular providers in the care of their patients. This idea originated from numerous conversations and discussions between myself and Dr. Kassardjian, beginning over 10 years ago. We are thrilled to see our challenges and hard work together with Drs. Bacher, Narayanaswami, and all the voting content experts culminate in this way, and we believe it will make a meaningful impact in the field. We would also like to thank the AANEM and the PIRP committee to support us in convening this task force allowing the culmination of this work.”
Do you have any ideas for a new guideline or consensus statement? Submit your ideas to AANEM!
Questions or thoughts about the new Consensus Guidance? Email the AANEM policy department at policy@aanem.org.